Your browser version may not work well with NCBI's Web applications. More information here...
1: Drugs Today (Barc). 2004 Dec;40(12):1013-30.Click here to read Links

Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndrome.

Cole P, Rabasseda X.

Medical Information Department, Prous Science, Provença 388, 08025 Barcelona, Spain. xrabasseda@prous.com

Activation of serotonin 5-HT(4) receptors has been proposed as treatment for irritable bowel syndrome, a common, complex and distressing gastrointestinal disorder. Abnormal intestinal motility and sensitivity in irritable bowel syndrome patients can result in diarrhea, constipation, abdominal pain, bloating, headache and fatigue; these and other symptoms can lead to exacerbation of psychological stress, which may in turn induce further physiological abnormalities and patient discomfort. The serotonin agonist tegaserod binds with high affinity to 5-HT(4) receptors and has demonstrated potent pharmacological effects on the mid- and distal gut. Tegaserod has been safely employed in clinical trials where it has demonstrated efficacy in normalizing intestinal function, thereby improving irritable bowel syndrome symptoms. (c) 2004 Prous Science. All rights reserved

PMID: 15645012 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Tegaserod (Zelnorm® )

    Tegaserod is used to relieve pain, bloating, and constipation caused by irritable bowel syndrome (IBS; a condition that causes stomach pain, bloating, constipation, and diarrhea) in women whose main symptom is constipati...

  • Docusate (Docusate calcium, Stool softener, Sulfolax, ...)

    How do the drugs used to treat chronic constipation and irritable bowel syndrome with predominant constipation compare?

  • Source: AHFS Consumer Medication Information